Despite its importance, there is no well-validated method of measuring patients' concept of 'acceptable' risk of medical treatment. Numerical methods give widely varying results depending on the methodology. We have attempted to assess 'acceptable' risk using relative comparisons. We administered a questionnaire to 67 patients with rheumatoid arthritis (RA). In general, patients' estimate of acceptable risk was less than the actual risk of treatment. Some illogical choices were made, showing poor understanding by patients of the concepts of risk and risk:benefit ratio. Patients appeared willing to accept higher levels of risk from procedures than from drug treatment. Willingness to accept risk in exchange for successful treatment of their RA did not correlate with disease severity, age, willingness to take non-medical risks or family responsibilities.
T concept of risk:benefit ratio is central to medicine.
would regard as an acceptable risk of flying to a foreign holiday destination and of being a regular It is also increasingly recognized that patients should be aware of the risks of medical treatment [1, 2] . Other cigarette smoker. Risk is reported as safety degree units (SDUs) [4] , which represent the log of the factors, such as the patient's prior perception of risk, may be important in the patient's overall perception reciprocal of the numerical risk, e.g. 1/1000 risk = log 103 SDU = 3 SDU. Non-parametric statistics were of the risk from a particular treatment [3, 4] . In his Heberden Oration, Sir Kenneth Calman highlighted used. Details of age, sex, disease duration, current drug treatment, pain score, Stanford Health Assessment the importance of understanding perception of risk and communicating risks of treatment to individuals Questionnaire (HAQ), smoking habits and family responsibilities (marital status and number of dependand to the public [2] . Previous work has shown that what patients, and also doctors, regard as an acceptable ent children) were also recorded. Approval was obtained from the Tayside Committee risk of drug treatment may be unrealistic [5] and is dependent on methodology [5] [6] [7] . In an attempt to on Medical Research Ethics. overcome the latter problem, we have attempted to assess 'acceptable' risk to patients of drug treatment RESULTS using a descriptive, relative, non-numerical scale, Forty-nine females and 18 males were studied, 19 avoiding the requirement for patients to attempt to were smokers, two ex-smokers and 45 non-smokers, relate to a numerical scale.
one whose smoking history was not recorded. The median age was 57 yr (range 15-80) and median PATIENTS AND METHODS disease duration was 10 yr (range 1-30). Sixty-seven patients with rheumatoid arthritis (RA)
Patients' views of acceptable risk are shown in attending our clinic were studied. Patients were chosen Table I . Patients were willing to accept a greater risk from the clinic at random. The questionnaire consisted of death for complete cure of their RA than for 30% of a series of 18 cm horizontal logarithmic scales with improvement ( Wilcoxon P = 0.04). However, patients 2 cm divisions, marked at one end 'almost impossible' were no more willing to accept death as an adverse and at the other 'certain death'. Further descriptors effect of drug treatment offering complete cure than were inserted along the scale, e.g. risk of being struck they were as an adverse effect of total hip replacement by lightening. The extremes of the scale represented ( Wilcoxon P = 0.058) and, paradoxically, were more risks of 100 and 109. Each scale represented the probabwilling to accept death from a total hip replacement ility of death as an adverse effect which the patient than from a drug treatment offering 30% overall would regard as acceptable for certain potentially improvement ( Wilcoxon P = 0.04). 'Complete cure' of beneficial situations. The potentially beneficial situarthritis was seen as more risk worthy than going on ations given were: complete cure of their arthritis, 30% a foreign holiday ( Wilcoxon P < 0.001), but less so improvement in symptoms, prevention of further than undergoing a coronary angiogram ( Wilcoxon deterioration and total hip replacement. Patients were P = 0.04). Furthermore, on 21 occasions, patients also given the scenario of having intractable angina appeared willing to accept a greater probability of pectoris and asked about the acceptable risk of corondeath for a lesser drug-related therapeutic outcome, ary angiography. Patients were also asked what they e.g. would accept a greater risk for 'no deterioration' than for '30% improvement'. Willingness to accept the risk of travelling to a foreign holiday destination did patients did mention that they had experienced reac-DISCUSSION tions, but there appeared to be no consistent effect of this on the level of risk acceptable from drug treatment. Using this method, the 'acceptable' level of risk was Overall, it seems that patients with RA have a poor lower by a factor of~25-40 than the real risk of understanding of risk and of risk:benefit ratios. This current drug therapy [8] . This compares with our is likely to be especially so when these relate to drug previous study using a different method where the treatment. 'acceptable' level of risk differed from the actual level by a factor of~10 000 [5] and also from studies [6,
R 7] using a standard gamble technique, where a 20-27%
